BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioTech New Zealand - ECPv6.10.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioTech New Zealand
X-ORIGINAL-URL:https://biotechnz.org.nz
X-WR-CALDESC:Events for BioTech New Zealand
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Pacific/Auckland
BEGIN:STANDARD
TZOFFSETFROM:+1300
TZOFFSETTO:+1200
TZNAME:NZST
DTSTART:20200404T140000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1200
TZOFFSETTO:+1300
TZNAME:NZDT
DTSTART:20200926T140000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Pacific/Auckland:20200430T150000
DTEND;TZID=Pacific/Auckland:20200430T160000
DTSTAMP:20260524T101017
CREATED:20200413T230633Z
LAST-MODIFIED:20200413T231247Z
UID:1566-1588258800-1588262400@biotechnz.org.nz
SUMMARY:WEBINAR: Stem cells use in acute respiratory distress syndrome\, a complication of COVID-19
DESCRIPTION:THIS IS A TECH ALLIANCE ASSOCIATION EVENT\, FREE FOR ALL ATTENDEES.\n  \nHear from Dr Stewart Washer\, Non-Executive Director of Cynata Therapeutics Limited an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology\, Cymerus™. \nCynata’s MSC Cymerus technology transforms induced pluripotent stem cells (iPSCs) into unlimited doses of MSCs that can be used as cell therapies. \nIn the webinar listen to Stewart talk about the potential of treating patients with ARDS (an inflammatory process leading to build-up of fluid in the lungs and respiratory failure)\, with stem cells and the role they play in treating COVID-19 patients.
URL:https://biotechnz.org.nz/event/webinar-the-use-of-stem-cells-in-acute-respiratory-distress-syndrome-ards-a-complication-of-covid-19/
LOCATION:Zoom (Webinar)\, New Zealand
CATEGORIES:BIOTechNZ Events
ATTACH;FMTTYPE=image/jpeg:https://biotechnz.org.nz/wp-content/uploads/sites/16/2020/04/shutterstock_197603171-web.jpg
GEO:-40.900557;174.885971
END:VEVENT
END:VCALENDAR